About Company
IVD R.E.D. was founded in 2018 and is built upon technologies developed by the research team from the Department of Power Mechanical Engineering at National Tsing Hua University. The company focuses on the development of advanced microfluidic technologies and integrated in vitro diagnostic (IVD) chips with strong international competitiveness.
In 2022, IVD R.E.D. was honored with the 19th National Innovation Award and has obtained patents in multiple countries. Our primary products include :
1. Your All-in-One Cellular Partner
(1) Cell Isolation Chip、(2) Automated Cell Dispensing System、(3) Automated Microfluidic Cell-Culture Control System, Precise medium perfusion (injection/drainage) with remote real-time monitoring.
2. AI Predicts Kidney Health Assessment: integrates data from health checkups and other diagnostic metrics for a comprehensive evaluation, enabling continuous monitoring and tracking for elderly and high-risk populations.
Product Info
1. Your All-in-One Cellular Partner
(1) Cell Isolation Chip: Direct cell isolation, eliminates time-consuming
dilution method (>28 days), optimized for Biopharma R&D and Clinical Diagnostic Centers.
(2) Automated Cell Dispensing System: Ultra-low residue and superior uniformity compared to manual operation, tailored for Cell Therapy Developers and Large-scale CDMOs.
(3) Automated Microfluidic Cell-Culture Control System: Precise medium perfusion (injection/drainage) with remote real-time monitoring for Multi-project R&D teams and Pharma requiring long-term tracking.
2.Comprehensive Kidney Car
(1)AI Predicts Kidney Health Assessment:This early-prevention predictive model analyzes physiological indicators from routine health checkups to provide actionable insights. By leveraging AI-driven analytics, it assists physicians in assessing the probability of kidney disease and mitigating the long-term risk of dialysis. The system is specifically designed for both healthy and sub-healthy populations, offering early warnings to proactively manage renal health.
(2) Early-Stage Kidney Disease Indicator Detection Device, CoreTest®:
Integrating fully-integrated bio-electronic chips with advanced components and dedicated instrumentation, this system delivers a robust Point-of-Care Testing (POCT) solution for clinical diagnostics. It enables continuous monitoring of high-risk populations by seamlessly uploading test results to the cloud. By integrating AI-driven predictions with patient longitudinal data, it provides a truly comprehensive health assessment.
Get in touch directly with us.